SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001016504-13-000015
Filing Date
2013-11-06
Accepted
2013-11-06 16:24:55
Documents
12
Effectiveness Date
2013-11-06

Document Format Files

Seq Description Document Type Size
1 inb_proxy2013a1.htm DEFA14A 206941
2 inb_001.jpg GRAPHIC 31459
3 inb_002b.jpg GRAPHIC 56479
4 inb_003.jpg GRAPHIC 57088
5 inb_004.jpg GRAPHIC 91384
6 inb_005a.jpg GRAPHIC 75830
7 inb_006.jpg GRAPHIC 36019
8 inb_007.jpg GRAPHIC 27647
9 inb_008.jpg GRAPHIC 51349
10 inb_009.jpg GRAPHIC 98718
11 inb010.jpg GRAPHIC 20238
12 inb_011c.jpg GRAPHIC 109647
  Complete submission text file 0001016504-13-000015.txt   1113028
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-31668 | Film No.: 131196775
SIC: 2834 Pharmaceutical Preparations